Europe Bacteriophages Therapy Market – Industry Trends and Forecast to 2031

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
back-icon

Back to Report
Home Pharmaceutical Europe Bacteriophages Therapy Market Table of Content
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Europe Bacteriophages Therapy Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Mar 2024
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
Buy Now Buy Now Request for Sample Request for Sample
Nucleus Nucleus

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW OF EUROPE BACTERIOPHAGES THERAPY market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. tareget LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
    1. porters five forces model
    2. pestel analysis
  5. EUROPE BACTERIOPHAGES THERAPY MARKET: REGULATIONS
    1. EUROPE REGULATORY GUIDELINE FOR BACTERIOPHAGE
  6. RESEARCH AND DEVELOPMENT ANALYSIS: EUROPE BACTERIOPHAGES THERAPY MARKET
    1. PIPELINE ANALYSIS
  7. Market Overview
    1. DRIVERS
      1. increasing prevalEnce of ANTIBIOTIC-RESISTANT INFECTIONS
      2. INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
      3. increasing government funding
      4. increasing private sector funding
      5. technological advancements
    2. RESTRAINTS
      1. HIGH COST ASSOCIATED WITH BACTERIOPHAGE THERAPY
      2. lack of skilled professionals
      3. SIDE-EFFECTS OF BACTERIOPHAGE THERAPY
      4. AVAILABILITY OF ALTERNATIVE THERAPIES FOR ANTIBIOTIC RESISTANCE
    3. OPPORTUNITIES
      1. PRESENCE OF NOVEL PIPELINE DRUGS
      2. strategic initiatives by market players
      3. INCREASING HEALTHCARE EXPENDITURE
    4. challenges
      1. LIMITations OF BACTERIOPHAGE Therapy
      2. lack of PROPER regulatory guidelines
  8. IMPACT OF COVID-19 ON EUROPE BACTERIOPHAGES THERAPY MARKET
    1. IMPACT ON THE PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY
    4. STRATEGIC INITIATIVES BY MANUFACTURERS
    5. CONCLUSION
  9. Europe bacteriophages therapy maRKET, BY TARGET
    1. overview
    2. STAPHYLOCOCCUS
    3. ESCHERICHIA COLI
    4. PSEUDOMONAS
    5. Streptococcus
    6. Salmonella
    7. OTHERS
  10. Europe bacteriophages therapy maRKET, BY TYPE
    1. overview
    2. lytic
    3. lysogenic
  11. Europe bacteriophages therapy maRKET, BY base
    1. overview
    2. Sterile broth culture
    3. water-soluble jelly base
  12. Europe bacteriophages therapy maRKET, BY application
    1. overview
    2. postoperative wound infections
    3. infections of skin and nasal mucosa
    4. bacterial dysentery
    5. suppurative skin infections
    6. lung and pleural infection
    7. OTHERS
  13. Europe bacteriophages therapy maRKET, BY route of administration
    1. overview
    2. oral
      1. LIQUID
      2. TABLET
    3. DERMal
    4. parenteral
      1. intrAVENOUSLY
      2. INTRAPLEURAL INJECTIONS
    5. OTHERS
  14. Europe bacteriophages therapy maRKET, BY end user
    1. overview
    2. hospitals
    3. specilaity clinics
    4. academic research & institutes
    5. OTHERS
  15. Europe bacteriophages therapy maRKET, BY distribution channel
    1. overview
    2. direct tender
    3. third party distributors
  16. EUROPE bacteriophages therapy MARKET, by COUNTry
    1. EUROPE
      1. Georgia
      2. RUSSIA
      3. Belgium
      4. POLAND
      5. France
      6. NETHERLANDS
      7. U.K.
      8. ITALY
      9. GERMANY
      10. TURKEY
      11. SWITZERLAND
      12. rest of europe
  17. EUROPE Bacteriophages Therapy Market: COMPANY landscape
    1. company share analysis: europe
  18. swot analysis
  19. company profile
    1. MICROGEN
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    2. FIXED-PHAGE LIMITED
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    3. MICREOS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    4. ATCC
      1. COMPANY SNAPSHOT
      2. COMPANY SHARE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. locus biosciences, INC.
      1. COMPANY SNAPSHOT
      2. COMPANY SHARE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. armata pharmaceuticals, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. Enbiotix, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. iNtODEWORLD, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. pherecydes Pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  20. questionnaire
  21. related reports

List of Table

TABLE 1 Europe bacteriophages therapy Market, By target, 2019-2028 (USD Million)

TABLE 2 Europe bacteriophages therapy Market, By type, 2019-2028 (USD Million)

TABLE 3 Europe bacteriophages therapy Market, By base, 2019-2028 (USD Million)

TABLE 4 Europe bacteriophages therapy Market, By application, 2019-2028 (USD Million)

TABLE 5 Europe bacteriophages therapy Market, By route of administration, 2019-2028 (USD Million)

TABLE 6 Europe oral in bacteriophages therapy Market, By Route of administration, 2019-2028 (USD MILLION)

TABLE 7 Europe parenteral in bacteriophages therapy Market, By Route of ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 8 Europe bacteriophages therapy Market, By end user, 2019-2028 (USD Million)

TABLE 9 Europe bacteriophages therapy Market, By distribution channel, 2019-2028 (USD Million)

TABLE 10 EUROPE BACTERIOPHAGES THERAPY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 11 GEORGIA BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 12 GEORGIA BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 13 GEORGIA BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 14 GEORGIA BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 15 GEORGIA BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 16 GEORGIA oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 17 GEORGIA parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 18 GEORGIA BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 19 GEORGIA BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 20 russia BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 21 RUSSIA BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 22 RUSSIA BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 23 RUSSIA BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 24 RUSSIA BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 25 RUSSIA oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 26 RUSSIA parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 27 RUSSIA BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 28 RUSSIA BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 29 BELGIUM BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 30 BELGIUM BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 31 BELGIUM BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 32 BELGIUM BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 33 BELGIUM BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 34 BELGIUM oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 35 BELGIUM parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 36 BELGIUM BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 37 BELGIUM BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 38 Poland BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 39 POLAND BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 40 POLAND BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 41 POLAND BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 42 POLAND BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 43 POLAND oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 44 POLAND parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 45 POLAND BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 46 POLAND BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 47 FRANCE BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 48 FRANCE BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 49 FRANCE BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 50 FRANCE BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 51 FRANCE BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 52 FRANCE oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 53 FRANCE parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 54 FRANCE BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 55 FRANCE BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 Netherlands BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 57 NETHERLANDS BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 58 NETHERLANDS BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 59 NETHERLANDS BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 60 NETHERLANDS BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 61 NETHERLANDS oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 62 NETHERLANDS parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 63 NETHERLANDS BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 64 NETHERLANDS BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 65 U.K. BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 66 U.K. BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 67 U.K. BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 68 U.K. BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 69 U.K. BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 70 U.K. oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 71 U.K. parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 72 U.K. BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 73 U.K. BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 74 Italy BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 75 ITALY BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 76 ITALY BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 77 ITALY BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 78 ITALY BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 79 ITALY oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 80 ITALY parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 81 ITALY BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 82 ITALY BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 83 GERMANY BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 84 GERMANY BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 85 GERMANY BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 86 GERMANY BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 87 GERMANY BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 88 GERMANY oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 89 GERMANY parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 90 GERMANY BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 91 GERMANY BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 92 Turkey BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 93 TURKEY BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 94 TURKEY BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 95 TURKEY BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 96 TURKEY BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 97 TURKEY oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 98 TURKEY parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 99 TURKEY BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 100 TURKEY BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 101 Switzerland BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

TABLE 102 SWITZERLAND BACTERIOPHAGES THERAPY Market, By Type, 2019-2028 (USD MIllion)

TABLE 103 SWITZERLAND BACTERIOPHAGES THERAPY Market, By BASE, 2019-2028 (USD Million)

TABLE 104 SWITZERLAND BACTERIOPHAGES THERAPY Market, By application, 2019-2028 (USD Million)

TABLE 105 SWITZERLAND BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 106 SWITZERLAND oral in BACTERIOPHAGES THERAPY Market, By route of administrATION, 2019-2028 (USD Million)

TABLE 107 SWITZERLAND parenteral in BACTERIOPHAGES THERAPY Market, By route of administration, 2019-2028 (USD Million)

TABLE 108 SWITZERLAND BACTERIOPHAGES THERAPY Market, By end user, 2019-2028 (USD Million)

TABLE 109 SWITZERLAND BACTERIOPHAGES THERAPY Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 110 rest of europe BACTERIOPHAGES THERAPY Market, By TARGET, 2019-2028 (USD Million)

List of Figure

FIGURE 1 Europe bacteriophages therapy market: segmentation

FIGURE 2 Europe bacteriophages therapy market: data triangulation

FIGURE 3 Europe bacteriophages therapy market: DROC ANALYSIS

FIGURE 4 Europe bacteriophages therapy market : Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 Europe bacteriophages therapy market : COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe bacteriophages therapy market: INTERVIEW DEMOGRAPHICS

FIGURE 7 Europe bacteriophages therapy market: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE bacteriophages therapy MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 Europe bacteriophages therapy market: vendor share analysis

FIGURE 10 Europe bacteriophages therapy market: SEGMENTATION

FIGURE 11 RISING INCIDENCE OF ANTIBIOTIC-RESISTANT INFECTIONS AND TECHNOLOGICAL ADVANCEMENTS are expected to drive THE Europe bacteriophages therapy market IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 Staphylococcus segment is expected to account for the largest share of the Europe bacteriophages therapy market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE Bacteriophages therapy MARKET

FIGURE 14 Europe bacteriophages therapy market: BY target, 2020

FIGURE 15 Europe bacteriophages therapy market: BY target, 2021-2028 (USD Million)

FIGURE 16 Europe bacteriophages therapy market: BY target, CAGR (2021-2028)

FIGURE 17 Europe bacteriophages therapy market: BY target, LIFELINE CURVE

FIGURE 18 Europe bacteriophages therapy market: BY type, 2020

FIGURE 19 Europe bacteriophages therapy market: BY type, 2021-2028 (USD Million)

FIGURE 20 Europe bacteriophages therapy market: BY type, CAGR (2021-2028)

FIGURE 21 Europe bacteriophages therapy market: BY type, LIFELINE CURVE

FIGURE 22 Europe bacteriophages therapy market: BY base, 2020

FIGURE 23 Europe bacteriophages therapy market: BY base, 2021-2028 (USD Million)

FIGURE 24 Europe bacteriophages therapy market: BY base, CAGR (2021-2028)

FIGURE 25 Europe bacteriophages therapy market: BY base, LIFELINE CURVE

FIGURE 26 Europe bacteriophages therapy market: BY application, 2020

FIGURE 27 Europe bacteriophages therapy market: BY application, 2021-2028 (USD Million)

FIGURE 28 Europe bacteriophages therapy market: BY application, CAGR (2021-2028)

FIGURE 29 Europe bacteriophages therapy market: BY application, LIFELINE CURVE

FIGURE 30 Europe bacteriophages therapy market: BY route of administration, 2020

FIGURE 31 Europe bacteriophages therapy market: BY route of administration, 2021-2028 (USD Million)

FIGURE 32 Europe bacteriophages therapy market: BY route of administration, CAGR (2021-2028)

FIGURE 33 Europe bacteriophages therapy market: BY route of administration, LIFELINE CURVE

FIGURE 34 Europe bacteriophages therapy market: BY end user, 2020

FIGURE 35 Europe bacteriophages therapy market: BY end user, 2021-2028 (USD Million)

FIGURE 36 Europe bacteriophages therapy market: BY end user, CAGR (2021-2028)

FIGURE 37 Europe bacteriophages therapy market: BY end user, LIFELINE CURVE

FIGURE 38 Europe bacteriophages therapy market: BY distribution channel, 2020

FIGURE 39 Europe bacteriophages therapy market: BY distribution channel, 2021-2028 (USD Million)

FIGURE 40 Europe bacteriophages therapy market: BY distribution channel, CAGR (2021-2028)

FIGURE 41 Europe bacteriophages therapy market: BY distribution channel, LIFELINE CURVE

FIGURE 42 EUROPE BACTERIOPHAGES THERAPY market: SNAPSHOT (2020)

FIGURE 43 EUROPE BACTERIOPHAGES THERAPY market: BY COUNTRY (2020)

FIGURE 44 EUROPE BACTERIOPHAGES THERAPY market: BY COUNTRY (2021 & 2028)

FIGURE 45 EUROPE BACTERIOPHAGES THERAPY market: BY COUNTRY (2020 & 2028)

FIGURE 46 EUROPE BACTERIOPHAGES THERAPY market: BY target (2021-2028)

FIGURE 47 EUROPE Bacteriophages Therapy Market: company share 2020 (%)

Frequently Asked Questions

The major companies in the Europe Bacteriophages Therapy Market are Microgen (India), Micreos (Netherlands), ATCC (U.S.), Intralytix, Inc. (U.S.), Adaptive Phage Therapeutics, Inc. (U.S.), Armata pharmaceuticals Inc. (U.S.), LOCUS BIOSCIENCES, INC. (U.S.), Delmont Laboratories, Inc. (U.S.), Pherecydes Pharma (France), iNtRON Biotechnology, Inc. (U.S.), Fixed-Phage Limited (U.K.), Cytophage Technologies Inc. (Canada), Eliava Biopreparation LLC (Georgia), Phagelux, Inc. (China), TechnoPhage (Portugal), Eligo Bioscience (France), BiomX Inc. (Israel).
The Europe Bacteriophages Therapy Market growth rate is 5.1% during the forecast period.
The Rising Potential for Personalized Medicine for Treatment Effectiveness and Increasing Prevalence of Chronic Diseases Creates Demand for Antibacterial Solutions are the growth drivers of the Europe Bacteriophages Therapy Market.
The target, type, base, disease indication, application, route of administration, end-user, and distribution channel are the factors on which the Europe Bacteriophages Therapy Market research is based.
The Europe Bacteriophages Therapy Market size will be worth USD 22.80 million by 2031 during the forecast period.

Browse Related Pages

Banner